Pricing Log in Create free account

Apimeds Pharmaceuticals US, Inc. (APUS) vs Universe Pharmaceuticals INC (UPC)

Apimeds Pharmaceuticals US, Inc. and Universe Pharmaceuticals INC are both Drug Manufacturers Specialty & Generic companies. Universe Pharmaceuticals INC is the larger, with a market value of $7.0M against $4.1M — 1.7× the size. Apimeds Pharmaceuticals US, Inc. has the higher net margin (0.00% vs −6.42%) and the lower return on invested capital (−16.0% vs 0.00%). Across the 10 metrics below, Universe Pharmaceuticals INC leads on 7 and Apimeds Pharmaceuticals US, Inc. on 3.

Valuation

Metric APUS UPC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S n/m n/m 2.08
P/B 0.04 n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m 8.52 12.22
EV/Sales n/m (0.24) 2.87
Earnings yield (1,394.72%) (105.04%) (15.94%)
Free cash flow yield (295.94%) 0.00% 0.00%

Profitability

Metric APUS UPC Drug Manufacturers Specialty & Generic median
Gross margin — 49.77% 53.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (6.42%) (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (100.13%) 0.00% (0.80%)
Return on assets (84.20%) 0.00% (1.67%)
Return on invested capital (15.96%) 0.00% 0.00%

Growth

Metric APUS UPC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — — 5.22%
EPS growth (last fiscal year) (205.56%) 98.71% 42.91%
Revenue growth, 5-year CAGR — (10.27%) 7.24%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric APUS UPC Drug Manufacturers Specialty & Generic median
Debt to equity 0.08 0.17 0.04
Current ratio 0.51 4.05 2.41
Net debt to EBITDA 0.38 10.15 1.01

Dividend

Metric APUS UPC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric APUS UPC Drug Manufacturers Specialty & Generic median
Market cap 4.12m 7.04m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack